Drug firm Sun Pharma today said it has received US regulatory approval to market Roxicodone, Oxycodone hydrochloride tablets used as painkillers.

In a filing to the Bombay Stock Exchange, Sun Pharmaceutical Industries said its subsidiary has received US Food and Drug Administration approval (USFDA) to market Roxicodone, Oxycodone hydrochloride tablets used as a painkiller.

The tablets are in the strength of 5mg, 15mg and 30mg and is used as a narcotic painkiller in the treatment of moderate to severe pain. These products would reach the US market shortly, the filing added.

New Ipad Application :Business Standard's all new IPad App Click here to download for free Other Stories      - Wall Street up on Greece, but gains seen limited - Civic polls: Saffron alliance retains Mumbai, Thane - MCX awaits trading rules in commodity options, indices - Govt to provide incentives for electronic chip manufacturing - Sure to buy French Rafale jets: Indian Air Force

Tags : Sun Pharma | Pharma industry | US FDA   Read Business news in  Advertisements -  Now property search gets more exciting than ever before! -  High Growth Business Opportunities in Africa - Register to explore -  Medium-sized businesses are the engines of a smarter planet. -  Save over Rs.3000 with IndianOil Citibank Card -  India's No. 1 Property Site. Click here to know more.. -  Get 5% cashback on telephone bills with Citi -  Diseases earlier, Saving Costs, Extending Lives. Know More.. -  Enjoy the journey as much as the destination. click to know more.. -  Exim Bank Conclave on India - Africa Project Partnership. Know more.. -  Creating Wealth made simple the SIP way. Know more.. -  Only Developer to give a guarantee on time space & rate. -  Office 365 for professionals and small businesses. -  Buy Your Property with Our Triple Guarantee in India. -  Improve Patient Care & Experience. Click here to know more -  Win a Business Class Ticket to Europe..Know more.. -   Introduce a New Automotive Luxury Car.. know more